ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $136,000 | -55.7% | 133,840 | -39.9% | 0.02% | -59.5% |
Q2 2021 | $307,000 | -14.7% | 222,619 | +4.9% | 0.04% | -36.2% |
Q1 2021 | $360,000 | +37.4% | 212,238 | +0.1% | 0.06% | +5.5% |
Q4 2020 | $262,000 | -13.0% | 212,052 | 0.0% | 0.06% | -25.7% |
Q3 2020 | $301,000 | +144.7% | 212,052 | +108.0% | 0.07% | +111.4% |
Q2 2020 | $123,000 | -0.8% | 101,965 | -2.7% | 0.04% | -16.7% |
Q1 2020 | $124,000 | – | 104,795 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |